Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2006; 12(4): 561-567
Published online Jan 28, 2006. doi: 10.3748/wjg.v12.i4.561
Published online Jan 28, 2006. doi: 10.3748/wjg.v12.i4.561
Table 3 Forward stepwise logistic regression analysis for all independent factors contributing to virological response
Factors | Odds ratio | 95% CI | P |
(At baseline) | |||
HBV DNA less than 6.81 | 434.7 | 104.1 - 2000 | < 0.0001 |
HBeAg negativity | 7.142 | 2.136 - 238.0 | < 0.0001 |
Platelet count more than 10 0x 109/L | 4.625 | 1.242 - 17.22 | 0.0224 |
(During treatment) | |||
Decline of HBV-DNA more than 3.21 | 51.13 | 11.21 - 233.0 | < 0.0001 |
within 3 mo of the start of treatment |
- Citation: Furusyo N, Takeoka H, Toyoda K, Murata M, Tanabe Y, Kajiwara E, Shimono J, Masumoto A, Maruyama T, Nomura H, Nakamuta M, Takahashi K, Shimoda S, Azuma K, Sakai H, Hayashi J, Group TKULDS. Long-term lamivudine treatment for chronic hepatitis B in Japanese patients: A project of Kyushu University Liver Disease Study. World J Gastroenterol 2006; 12(4): 561-567
- URL: https://www.wjgnet.com/1007-9327/full/v12/i4/561.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i4.561